Cargando…
The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
Gout is an autoinflammatory disease caused by monosodium urate mono hydrate crystal deposition in tissues or the supersaturation of extracellular fluids of uric acid. In this study, we are going to report the experience of the Asklepeion Voula Rheumatology Clinic, treating four patients with gouty a...
Autores principales: | Theotikos, Evangelos, Raftakis, Ioannis, Elezoglou, Antonia, Antoniadis, Christodoulos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045930/ https://www.ncbi.nlm.nih.gov/pubmed/32185254 http://dx.doi.org/10.31138/mjr.28.1.48 |
Ejemplares similares
-
Pulmonary fibrosis and microscopic polyangiitis in a 75-year-old woman
por: Koutsoviti, Sofia, et al.
Publicado: (2019) -
Off-label use of canakinumab in pediatric rheumatology and rare diseases
por: Del Giudice, Emanuela, et al.
Publicado: (2022) -
Gouty panniculitis: A case series
por: Negbenebor, Nicole A., et al.
Publicado: (2021) -
Septic Arthritis Complicating a Gout Flare: Report of Two Cases and Review of the Literature
por: Tzanis, Prokopios, et al.
Publicado: (2022) -
Spontaneous Chalk-Stick Fracture in Ankylosing Spondylitis: A Case Report
por: Katsimpari, Chaido, et al.
Publicado: (2022)